LIVE WEBINAR
Share:

Using EU GMP Annex 22 as the Framework for Governing AI Systems, Validation Traceability, and Data Integrity Controls

  • Date
    04 August 2026
  • 11.00 AM Eastern Time (US/Canada)
    03.00 PM GMT

Course is now LIVE. Click below to join the session.

This course helps organizations establish controlled AI governance through traceable validation, reliable data, monitored performance, managed change, accountable decisions, and inspection-ready lifecycle evidence aligned with EU GMP Annex 22. 

/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }
REGISTRATION OPTIONS

Live session Plus
Complimentary 30 Days Streaming access

$290  |  One participant (viewer)

$390  |  Team (2 - 5 participants)

$490 |  Team (6 - 10 participants)

REGISTER FOR THE COURSE

US $290 per learner

30-Days Unlimited Streaming Access

/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }

REGISTER FOR THE COURSE

To Get 30-Day Access to ONLY this Course 

US $290 per learner
  • This course is Included in Subscription Pack
Subscription include access to entire Learning Library
/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }
  • Faculty
    Charles H. Paul
  • Duration
    60 Minutes
  • Course ID
    TF1608
  • Live Q&A +
    Post-live Continued Learning
  • Presentation Handout
    & Templates
  • Assessment
    & Certification Included

 

Why take this course?

AI-enabled systems are increasingly used across pharmaceutical, biotechnology, medical device, and advanced therapy operations for manufacturing support, investigations, process monitoring, document generation, supplier oversight, risk assessment, and other GMP activities. Unlike conventional software, these systems may rely on large training datasets, produce probabilistic outputs, adapt over time, and experience drift or performance degradation. These characteristics create governance and validation challenges that fixed-logic approaches may not fully address. 


This webinar examines how EU GMP Annex 22 can structure oversight of AI systems across validation traceability, lifecycle management, data integrity, accountability, and inspection readiness. Participants will consider training data controls, source reliability, output verification, auditability, model monitoring, retraining, change management, supplier qualification, and human decision responsibility. The emphasis is on maintaining evidence of continued fitness for intended use while integrating AI controls into established quality systems and operational processes throughout the operational system lifecycle.

Strengthen AI Governance Before Inspection 

Organizations using AI in GMP activities must be prepared to explain intended use, risk classification, model validation, training data controls, output verification, and continued performance. This session strengthens the ability to identify governance gaps before they affect product quality, patient safety, operational reliability, or inspection outcomes. 

Connect Initial Validation with Ongoing Control 

The discussion progresses from AI classification, intended use, governance roles, and validation foundations into data controls, monitoring, retraining, change management, supplier oversight, and inspection evidence. This sequence connects initial control decisions with the ongoing activities required to maintain confidence in system performance throughout use.

Key Areas Covered

  • EU GMP Annex 22 expectations for AI governance 
  • AI classification and risk-based oversight approaches
  • Validation traceability for adaptive and probabilistic systems
  • Training data governance, reliability, and access controls 
  • Output verification, auditability, and human accountability
  • Model monitoring, drift detection, and performance degradation
  • Retraining, change management, and lifecycle documentation
  • Supplier qualification and inspection readiness for AI systems 

Who Must Attend

  • Quality Assurance Departments
  • Regulatory Affairs Departments
  • Manufacturing Departments
  • Operations Departments
  • GMP Compliance Professionals
  • Validation Departments
  • Computer System Validation Specialists
  • Digital Transformation Leaders
  • Data Integrity Specialists
  • IT Quality Managers
  • Automation Engineers
  • Process Engineers
  • Internal Auditors
  • Supplier Quality Professionals
  • AI Governance Teams
  • Executive Leadership Teams
Charles H. Paul
COURSE DIRECTOR

Charles H. Paul 

Charles H. Paul has more than 30 years of experience supporting regulated organizations in GMP compliance, quality systems, validation programs, computerized systems oversight, technical documentation, risk management, and inspection readiness. His work aligning regulatory expectations with operational controls directly supports the governance, traceability, data integrity, and lifecycle challenges addressed in this webinar. 

If you would like to request a Proforma invoice to sign up for this course. please click here

Commonly Asked Questions About This Subject

The following questions address practical regulatory, compliance, validation, quality, operational, and inspection-related considerations commonly associated with this subject.

How can an organization demonstrate that AI governance is functioning effectively rather than existing only as documented policy? 

Inspection discussions often move quickly beyond governance documents and focus on how decisions are made during routine operations. Policies, organizational charts, and committee structures provide limited assurance if day-to-day activities do not consistently reflect them. 


Reviewers frequently examine recent AI-related changes, investigations, deviations, model updates, performance reviews, and risk assessments to determine whether governance is influencing operational decisions. Gaps become visible when responsibilities are unclear, approvals occur without meaningful evaluation, or significant AI-related activities proceed outside established quality processes. 


Evidence carrying greater weight includes documented governance decisions, records of periodic performance review, traceable approval of model changes, investigation of unexpected outputs, and management actions taken when performance concerns emerged. 


Governance becomes much easier to defend when it consistently influences operational behavior instead of serving primarily as administrative documentation supporting regulatory expectations. 

What makes validation traceability for AI systems difficult to maintain throughout the operational lifecycle? 

Validation traceability becomes increasingly difficult when organizations treat validation evidence as static while the surrounding operating environment continues to change. Data sources, business processes, interfaces, software components, intended uses, and supporting models may all evolve over time even though the original validation remains formally approved. 


Inspection concerns often arise because individual changes appear adequately managed in isolation while cumulative effects gradually weaken traceability between requirements, testing, operational performance, and ongoing system suitability. 


Documentation becomes difficult to defend when reviewers cannot easily connect current system behavior to the evidence supporting its original acceptance. Missing links frequently emerge after multiple software updates, retraining activities, process modifications, or infrastructure changes. 


Strong lifecycle management preserves clear relationships between validated requirements, implemented functionality, operational monitoring, change history, and continuing evidence demonstrating that the system remains fit for its intended GMP use. 

When should changes to training data be treated as quality system changes rather than routine operational activities? 

A practical decision point arises when updated training data could reasonably influence how the AI system performs within regulated operations. The concern extends beyond whether new information was added and focuses instead on whether the system's behavior, recommendations, classifications, or analytical performance could change as a result. 


Inspection friction develops when organizations manage training data as an information technology activity without evaluating its potential quality impact. Reviewers frequently ask how changes were assessed, what performance was re-examined, and what evidence demonstrates continued suitability after the update. 


Documentation becomes more persuasive when the organization records why the training data changed, how associated risks were evaluated, what verification activities were performed, and why existing validation evidence remains sufficient or requires expansion. 


Those records demonstrate that changes to training data receive the same disciplined evaluation expected for other GMP-relevant modifications.

What creates the weakest inspection position when AI-generated content becomes part of GMP documentation? 

A documentation concern develops when AI-generated information enters controlled records without preserving evidence of how its accuracy, completeness, and suitability were evaluated. Reviewers generally place greater emphasis on the organization's review process than on the technology used to generate the content. 


Inspection questions often arise after discovering technical reports, investigations, procedures, risk assessments, or validation records containing statements that cannot be traced to supporting evidence. Those situations become increasingly difficult to explain if documentation simply reflects acceptance of generated content without recorded evaluation. 


Evidence supporting stronger control includes documented review criteria, verification against authoritative source information, clear attribution of supporting evidence, records of identified corrections, and traceability showing how final approved content was established. 


Organizations generally maintain a stronger regulatory position when generated content becomes the starting point for documented evaluation rather than the final version accepted into the quality system. 

Your TalkFDA Webinar Experience

When you reserve your seat, everything is organized for you — from access to certification from one place.

1. Confirmation

You receive a confirmation email and your course appears instantly in your TalkFDA dashboard.

2. Your Course Hub
Your TalkFDA course page becomes your central hub where you can join the session, access materials, and manage your learning.

3. Join the Live Training
At the scheduled time, click Join Session and you’ll be connected to the live Webex session with the instructor.

4. Watch Again Anytime
After the session, the playback becomes available on the same course page so you can revisit important sections.
5. Earn Your Certificate
Complete the course and your certificate is unlocked automatically in your learning history.

Everything related to your webinar: access, materials, playback, and certification — lives in one place.
Simple. Organized. Professional.
Go ahead and reserve your seat with confidence.

Built on 20+ years of global regulatory training experience across FDA, EMA, MHRA, and ICH frameworks.
Trusted by professionals across 80+ countries.

Testimonials

This is an upcoming session. Feedback below reflects experiences from similar programs delivered by our expert faculty.

“Session was easy to follow even for non-core team members. That helped.”
- Production Officer
“Good balance. Not too basic, not too deep. Worked well for mixed team.”
- Manager, Regulatory Affairs
“Team found it useful. Especially for aligning understanding across functions.”
- Director, Operations

Ready to Strengthen Your Team? Let’s Build Your Training Plan.

Whether you’re looking for a single onsite workshop or a multi-team training series, we’ll help you design a program that fits your goals, timelines, and operational reality.

Your team deserves the clarity.
Your organization deserves the confidence.

Upcoming Courses

Featured Courses